Aimmune Therapeutics Inc. (NASDAQ:AIMT) announced the closing of its initial public offering of 11,499,999 shares of its common stock
(Business Wire) Aimmune Therapeutics Inc. (NASDAQ:AIMT) announced the closing of its initial public offering of 11,499,999 shares Read More